Immutep (IMMP) Cash from Operations (2011 - 2024)
Immutep's (IMMP) quarterly Cash from Operations came in at 22948042.51 in Q2 2024, up 2.89% YoY from 22303958.69 in Q3 2023, and up 2.89% on a QoQ basis from 23630431.63 in Q2 2023.
Immutep (IMMP) Cash from Operations (2011 - 2024) Analysis & Trends
Immutep (IMMP) has 11 years of Cash from Operations data on file, last reported at 22948042.51 in Q2 2024.
- Quarterly Cash from Operations rose 2.89% year-over-year to 22948042.51 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was 64390498.48 (down 34.62% YoY) and the FY2025 annual result came in at 39738691.97, down 73.17% from the prior year.
- Cash from Operations rose to 22948042.51 in Q2 2024, from 23630431.63 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 7104326.36 in Q2 2020 to a low of 23630431.63 in Q2 2023.
- A 3-year average of 17894266.83 and a median of 22948042.51 in 2024 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2020 — Cash from Operations soared 33.65% — and 2024, when it gained 2.89%.
- Tracing IMMP's Cash from Operations over 3 years: stood at 7104326.36 in 2020, then plunged by 232.62% to 23630431.63 in 2023, then increased by 2.89% to 22948042.51 in 2024.
- The last three Cash from Operations figures came in at 22948042.51 (Q2 2024), 23630431.63 (Q2 2023), and 7104326.36 (Q2 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | Immutep | 56.46 Mn | -8.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -22.95 Mn |
| Jun 30, 2024 | -22.95 Mn |
| Jun 30, 2023 | -23.63 Mn |
| Jun 30, 2023 | -23.63 Mn |
| Jun 30, 2020 | -7.10 Mn |
| Jun 30, 2020 | -7.10 Mn |
| Jun 30, 2019 | -10.71 Mn |
| Jun 30, 2019 | -10.71 Mn |
| Jun 30, 2017 | -6.39 Mn |
| Jun 30, 2017 | -6.39 Mn |
| Jun 30, 2016 | -8.44 Mn |
| Jun 30, 2016 | -8.44 Mn |
| Jun 30, 2015 | -6.05 Mn |
| Jun 30, 2015 | -6.05 Mn |
| Jun 30, 2014 | -13.27 Mn |
| Jun 30, 2014 | -13.27 Mn |
| Jun 30, 2013 | -15.93 Mn |
| Jun 30, 2013 | -15.93 Mn |
| Jun 30, 2012 | -19.32 Mn |
| Jun 30, 2012 | -19.32 Mn |